S&P 500 Futures
(0.25%) 5 535.50 points
Dow Jones Futures
(0.15%) 39 527 points
Nasdaq Futures
(0.30%) 19 988 points
Oil
(0.77%) $82.17
Gas
(-1.00%) $2.58
Gold
(-0.19%) $2 335.10
Silver
(-0.15%) $29.52
Platinum
(0.42%) $1 006.10
USD/EUR
(-0.47%) $0.929
USD/NOK
(-0.62%) $10.61
USD/GBP
(-0.22%) $0.789
USD/RUB
(1.63%) $87.12

Realaus laiko atnaujinimai Sarepta Therapeutics, [0L35.L]

Birža: London Stock Exchange Sektorius: Healthcare Pramonė: Medical - Pharmaceuticals
Atnaujinta28 birž. 2024 @ 20:55

1.37% $ 158.65

Live Chart Being Loaded With Signals

Commentary (28 birž. 2024 @ 20:55):
Our systems believe the stock currently is overvalued by -1.25% compare to its pairs and should correct downwards.
Profile picture for Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases...

Stats
Šios dienos apimtis 351
Vidutinė apimtis 424
Rinkos kapitalizacija 15.00B
EPS $0.380 ( Q1 | 2024-05-01 )
Kita pelno data ( $0 ) 2024-07-30
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -37.02
(Sector) 0
(Industry) 0
ATR14 $1.006 (0.64%)